Europe Excluding Germany was Bruker’s largest region in fiscal 2025, bringing in $1.90B of $6.87B (28%).
| Geography | FY 2010 | FY 2014 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Excluding Germany | — | $1.40B | $1.75B | $1.90B | ||||||||
| United States | $1.39B | $1.56B | $1.88B | $1.78B | ||||||||
| Revenues | — | — | — | — | ||||||||
| Rest Of Europe | $1.18B | — | — | — | ||||||||
| Asia Pacific | — | — | — | — | ||||||||
| Asia Pacific Excluding China | — | $921.80M | $1.04B | $1.11B | ||||||||
| China | $793.00M | $1.06B | $942.40M | $951.60M | ||||||||
| Rest Of Asia Pacific | $816.80M | — | — | — | ||||||||
| Germany | $494.80M | $563.00M | $621.40M | $594.00M | ||||||||
| Other | $380.80M | $433.20M | $509.00M | $539.20M | ||||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
Bruker brought in $6.87B from its six regions in fiscal 2025, the year ended December 31, 2025. That was up 2.1% from $6.73B in fiscal 2024. Europe Excluding Germany was the largest at $1.90B (27.7%), ahead of United States at $1.78B (25.9%) and Asia Pacific Excluding China at $1.11B (16.1%). The other three regions brought in $2.08B combined.
Compared with fiscal 2024, Europe Excluding Germany grew fastest, up 8.8% to $1.90B, while United States fell the most, down 5.0% to $1.78B.
Bruker began breaking out Europe Excluding Germany in fiscal 2023 and Asia Pacific Excluding China in fiscal 2023. Bruker stopped reporting Rest Of Europe ($1.18B in fiscal 2022) and Rest Of Asia Pacific ($816.80M in fiscal 2022) as separate regions.
Bsi Calid was Bruker’s largest segment in fiscal 2025, bringing in $2.42B of $6.87B (35%).
| Segment | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bsi Life Science | — | — | — | — | ||||||
| Bsi | — | — | — | — | ||||||
| Bsi Calid | $1.64B | $1.92B | $2.19B | $2.42B | ||||||
| Bsi Nano | $1.57B | $1.88B | $2.20B | $2.17B | ||||||
| Bsi Biospin | $1.39B | $1.60B | $1.81B | $1.76B | ||||||
| Bruker Biospin | — | — | — | — | ||||||
| Bruker Calid | — | — | — | — | ||||||
| Bsi Material Science | — | — | — | — | ||||||
| Best | $449.60M | $527.40M | $537.80M | $526.40M | ||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
Bruker brought in $6.87B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 2.1% from $6.73B in fiscal 2024. Bsi Calid was the largest at $2.42B (35.2%), ahead of Bsi Nano at $2.17B (31.6%) and Bsi Biospin at $1.76B (25.6%). The remaining segment, Best, brought in $526.40M.
Compared with fiscal 2024, Bsi Calid grew fastest, up 10.7% to $2.42B, while Bsi Biospin fell the most, down 3.0% to $1.76B. From fiscal 2022 to 2025, combined revenue from these segments grew from $5.06B to $6.87B, a compound annual growth rate of 10.7%. Bsi Calid's share of the total rose from 32.5% to 35.2%.
Product Revenue was Bruker’s largest product and service line in fiscal 2025, bringing in $5.53B of $6.87B (81%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | — | $4.92B | $5.52B | $5.53B | ||||||
| Product | $4.22B | — | — | — | ||||||
| Service | — | — | — | — | ||||||
| Service & Other Revenue | $841.60M | $1.01B | $1.21B | $1.34B | ||||||
| Other | — | — | — | — | ||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
Bruker brought in $6.87B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 2.1% from $6.73B in fiscal 2024. Product Revenue was the largest at $5.53B (80.5%), ahead of Service & Other Revenue at $1.34B (19.5%).
Compared with fiscal 2024, Service & Other Revenue grew 10.4% to $1.34B and Product Revenue grew 0.3% to $5.53B.
Bruker began breaking out Product Revenue in fiscal 2023, when it brought in $4.92B. Bruker stopped reporting Product as a separate line after fiscal 2022, when it brought in $4.22B.
Bruker (BRKR) reports its revenue by geography, by segment and by product and service. In fiscal 2025, Europe Excluding Germany was its largest region, bringing in $1.90B (27.7% of the total), followed by United States at $1.78B (25.9%).
Europe Excluding Germany was Bruker's largest region in fiscal 2025, bringing in $1.90B, or 27.7% of the $6.87B total across its six regions.
Bsi Calid was Bruker's largest segment in fiscal 2025, bringing in $2.42B, or 35.2% of the $6.87B total across its four segments.
Product Revenue was Bruker's largest product and service line in fiscal 2025, bringing in $5.53B, or 80.5% of the $6.87B total across its two product and service lines.
Among Bruker's regions that make up at least 2% of revenue, Europe Excluding Germany grew fastest in fiscal 2025, up 8.8% from $1.75B to $1.90B.
Every figure comes from Bruker's annual financial filings, as reported. Each line keeps the name Bruker gives it, and years follow its fiscal calendar.
Bruker's revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.